Annandale Capital, LLC - CULLINAN ONCOLOGY INC ownership

CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 98 filers reported holding CULLINAN ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.5%.

Quarter-by-quarter ownership
Annandale Capital, LLC ownership history of CULLINAN ONCOLOGY INC
ValueSharesWeighting
Q3 2023$109
+0.9%
12,000
+20.0%
0.03%
-12.9%
Q2 2023$108
+5.9%
10,0000.0%0.03%
-3.1%
Q1 2023$102
-3.8%
10,0000.0%0.03%
-8.6%
Q4 2022$106
-99.9%
10,0000.0%0.04%
-25.5%
Q3 2022$128,00010,0000.05%
Other shareholders
CULLINAN ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
MPM BioImpact LLC 7,648,268$118,013,00021.52%
CHI Advisors LLC 2,476,720$38,215,00012.68%
Nextech Invest Ltd. 1,221,145$18,842,0004.96%
Foresite Capital Management V, LLC 1,143,006$17,637,0004.33%
Foresite Capital Opportunity Management V, LLC 381,002$5,879,0003.94%
BVF INC/IL 5,369,459$82,851,0003.01%
Boxer Capital, LLC 1,074,082$16,573,0000.64%
Logos Global Management LP 288,458$4,450,0000.46%
Birchview Capital, LP 45,114$696,0000.45%
Eventide Asset Management 1,440,145$21,665,0000.28%
View complete list of CULLINAN ONCOLOGY INC shareholders